[ad_1]
Modern pharmaceutical company wants to charge governments between $ 25 and $ 37 for a dose of its coronavirus vaccine. “That is a fair price considering the high cost to the health system if a person becomes seriously ill with Covid-19.”
This is what CEO Stephane Bancel told “Welt am Sonntag”. “We are not interested in the maximum benefit,” emphasized the manager. It was reported on Monday from EU circles that they wanted to buy millions of cans of Moderna in the future for a unit price of less than $ 25.
200 new jobs at Visp
The American biotechnology group Moderna is preparing to market its corona vaccine. The company recently completed the inclusion of the last subject in the pivotal efficacy study with the mRNA-1273 vaccine, which included 30,000 participants.
The pharmaceutical supplier Lonza had already signed a contract with Moderna in May for the production of the active ingredient Moderna on a larger scale. 200 new jobs will be created at the Visp VS plant. (pbe / SDA)
